(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 186.72%11.98M | 60.58%14.07M | -81.76%8.76M | 274.21%29.18M | -97.05%-15.37M | -13.81M | -81.76%8.76M | 115.08%48.03M | -48.02%7.8M | 33.04%-7.8M |
Net profit before non-cash adjustment | 186.21%6.71M | -72.45%3.96M | 504.25%14.36M | 233.84%3.44M | 69.11%4.35M | ---7.79M | 504.34%14.36M | -86.23%-3.55M | 43.19%-2.57M | 137.89%2.57M |
Total adjustment of non-cash items | 143.25%4.8M | -78.06%4.76M | 5.04%21.69M | 23.76%5.83M | 211.75%5.27M | ---11.1M | 5.04%21.69M | -17.14%20.65M | -30.54%4.71M | -178.69%-4.71M |
-Depreciation and amortization | 148.15%3.51M | -76.12%3.49M | -0.01%14.62M | 0.78%3.65M | 200.33%3.64M | ---7.29M | -0.01%14.62M | -14.04%14.62M | -21.09%3.62M | -199.83%-3.63M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 22.95%38.4K | ---- | ---- | ---- | ---- | 86.48%31.23K | ---- | ---- |
-Disposal profit | ---- | ---- | 65.20%-346.65K | ---- | ---- | ---- | ---- | -275.73%-996.17K | ---- | ---- |
-Net exchange gains and losses | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -133.86%-6.6K | ---- | ---- |
-Other non-cash items | 133.88%1.29M | -82.05%1.27M | 5.40%7.38M | 20.79%2.49M | 249.82%1.63M | ---3.81M | 17.28%7.07M | -14.26%7M | -15.69%2.06M | -146.14%-1.09M |
Changes in working capital | -90.86%464K | 119.61%5.35M | -188.24%-27.29M | 252.02%19.91M | -341.67%-24.98M | --5.07M | -188.24%-27.29M | 4,597.90%30.93M | -55.62%5.66M | 47.89%-5.66M |
-Change in receivables | -113.67%-10.49M | 162.31%65.2M | -211.11%-101.6M | -165.60%-13.04M | -91.66%-60.68M | --76.75M | -201.35%-104.63M | 401.15%91.44M | 218.54%19.87M | -314.40%-31.66M |
-Change in inventory | ---- | --0 | --0 | --0 | --0 | --0 | --0 | 1,069.82%649.93K | 343.09%256.93K | -252.05%-257K |
-Change in payables | 113.67%7.5M | -162.43%-50.88M | 255.34%81.5M | 142.89%13.55M | 30.82%41.33M | ---54.88M | 255.34%81.5M | -891.28%-52.46M | -147.89%-31.59M | 172.59%31.59M |
-Changes in other current assets | 120.55%3.45M | -115.71%-8.97M | 17.46%-7.19M | 13.31%19.39M | -5.61%-5.63M | ---16.8M | 79.72%-4.16M | 65.86%-8.71M | 146.87%17.12M | -129.65%-5.33M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -124.42%-860K | 541.35%3.52M | ||||||||
Interest received (cash flow from operating activities) | 354.91%571K | -169.14%-224K | ||||||||
Tax refund paid | -628.15%-713K | -131.26%-835K | 388.67%2.67M | -1,977.38%-1.38M | 1,780.30%1.24M | 135K | 388.76%2.67M | 60.94%-925.24K | 2.07%-66.24K | 108.99%66K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 166.61%11.27M | 15.76%13.23M | -75.73%11.43M | 170.03%31.33M | -225.05%-14.42M | ---16.91M | -71.38%11.43M | 135.97%47.1M | -40.76%11.6M | 65.50%-4.44M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -159.09%-884K | 106.31%408K | -202.62%-6.9M | -210.00%-931.23K | -251.21%-998K | --1.5M | -70.83%-6.47M | -17.13%-2.28M | 271.43%846.55K | 317.82%660K |
Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---180.38K | ---- | ---- |
Net investment property transactions | ---- | ---- | 128.77%433.47K | ---- | ---- | ---- | ---- | -336.21%-1.51M | ---- | ---- |
Interest received (cash flow from investment activities) | --301K | -78.78%390K | 96.28%1.84M | ---- | ---- | ---- | --1.84M | -24.26%936.28K | ---- | ---- |
Net changes in other investments | ---- | ---- | 17.05%-3.61M | ---- | ---- | ---- | ---- | 49.61%-4.35M | ---- | ---- |
Investing cash flow | -70.47%-583K | 117.22%798K | -11.64%-8.24M | 46.68%-2.27M | -218.81%-998K | ---342K | -16.76%-4.63M | 23.81%-7.38M | 48.34%-4.25M | 377.23%840K |
Financing cash flow | ||||||||||
Net issuance payments of debt | -134.82%-1.66M | -617.10%-14.06M | 116.68%2.72M | -592.23%-27.15M | 470.45%22.37M | --4.78M | 116.68%2.72M | -48.37%-16.3M | 90.19%-3.92M | -86.28%3.92M |
Increase or decrease of lease financing | -126.02%-528K | 88.40%-585K | 45.70%-5.05M | 56.27%-882.06K | -156.87%-1.15M | --2.03M | 45.69%-5.05M | 11.64%-9.29M | 21.33%-2.02M | 177.43%2.02M |
Interest paid (cash flow from financing activities) | ---3.04M | 93.47%-581K | -9.77%-8.9M | ---- | ---- | ---- | ---8.9M | 13.89%-8.1M | ---- | ---- |
Net other fund-raising expenses | 112.13%728K | -52.97%-5.52M | ---- | ---- | 13.23%-6.13M | ---6M | 17.04%-3.61M | ---- | ---- | -17.42%-7.07M |
Financing cash flow | -182.31%-7.98M | -39.89%-20.75M | 66.70%-11.22M | -705.85%-21.19M | 1,440.67%15.1M | --9.7M | 50.47%-14.83M | -9.00%-33.69M | 92.95%-2.63M | -105.64%-1.13M |
Net cash flow | ||||||||||
Beginning cash position | -37.70%11.1M | -31.07%17.81M | 30.45%25.84M | -52.95%9.94M | -60.32%10.26M | -31.07%17.81M | 30.46%25.84M | -51.02%19.81M | -53.83%21.12M | -33.62%25.84M |
Current changes in cash | 135.72%2.7M | 16.39%-6.72M | -233.28%-8.03M | 66.88%7.88M | 93.26%-318K | ---7.56M | -233.25%-8.03M | 129.20%6.03M | 118.20%4.72M | -169.43%-4.72M |
Effect of exchange rate changes | ---- | --0 | --0 | --0 | --0 | --0 | --0 | 133.86%6.6K | 337.67%3.6K | -144.44%-4K |
End cash Position | 34.55%13.8M | -37.70%11.1M | -31.07%17.81M | -31.07%17.81M | -52.95%9.94M | -60.32%10.26M | -31.07%17.81M | 30.45%25.84M | 30.45%25.84M | -53.83%21.12M |
Free cash flow | 168.36%9.84M | 224.34%12.75M | -90.45%4.21M | 164.58%31.25M | -428.54%-16.58M | ---14.39M | -88.92%3.93M | 153.13%44.16M | -36.53%11.81M | 76.17%-3.14M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data